Demo Sign up Log In

Neuberger High Yield Strategies Fund Inc. Common Stock (NHS)

Cost of Revenue

$3.40M

TTM · Period ending: Apr 30, 2026 · USD

NHS Cost of Revenue

Latest reported$3.40Mperiod endingApr 30, 2026

Latest reported$3.40Mperiod endingApr 30, 2026

NHS TTM Cost of Revenue ($0.00 → $3.40M)

TTM cost of revenue

High-resolution chart · PNG

NHS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Neuberger High Yield Strategies Fund Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period ending	Cost of Revenue (USD)
Apr 30, 2026	3,397,175
Oct 31, 2025	4,430,969
Apr 30, 2025	3,260,283
Oct 31, 2024	2,183,938
Apr 30, 2024	3,113,122
Oct 31, 2023	1,986,214
Apr 30, 2023	3,024,700
Oct 31, 2022	4,102,411
Apr 30, 2022	3,173,227
Oct 31, 2021	2,116,197
Apr 30, 2021	4,006,738
Oct 31, 2020	2,929,027
Apr 30, 2020	2,929,027
Oct 31, 2019	2,929,027
Apr 30, 2019	0
Oct 31, 2018	0
Apr 30, 2018	40,000
Oct 31, 2017	40,000
Apr 30, 2017	80,000
Oct 31, 2016	80,000
Apr 30, 2016	40,000
Oct 31, 2015	40,000
Apr 30, 2015	0
Oct 31, 2014	0
Apr 30, 2014	0
Oct 31, 2013	0
Apr 30, 2013	0
Oct 31, 2012	0
Apr 30, 2012	0
Dec 31, 2009	0
Jun 30, 2009	0
Dec 31, 2008	0
Jun 30, 2008	0
Dec 31, 2007	0
Jun 30, 2007	0
Dec 31, 2006	0
Jun 30, 2006	0
Dec 31, 2005	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.